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HMGB1 in the pathogenesis of ultraviolet-induced
ocular surface inflammation
SJ Han1,7, HJ Min2,3,7, SC Yoon1,7, EA Ko3,4, SJ Park3,4, J-H Yoon3,5,6, J-S Shin*,3,4,6 and KY Seo*,1
High-mobility group box 1 (HMGB1) functions as a transcription-enhancing nuclear protein as well as a crucial cytokine that
regulates inflammation. This study demonstrated that secretion of HMGB1 due to ultraviolet (UV) radiation inducing ocular surface
inflammation-mediated reactive oxygen species (ROS) production. After treating conjunctival epithelial cells with UV radiation,
HMGB1 was translocated from the nucleus to the cytoplasm and then eventually to the extracellular space. HMGB1 played a crucial
role in UV-induced conjunctival neutrophil infiltration, which subsided when mice were pretreated with the HMGB1 inhibitors
soluble receptor for advanced glycation endproducts (sRAGEs) and HMGB1 A box protein. In case of using ROS quencher, there
was decrease in UV-induced HMGB1 secretion in conjunctival epithelial cells and mice. Considering that UV-induced chronic
inflammation causes ocular surface change as pterygium, we have confirmed high HMGB1 translocation and ROS expression
in human pterygium. Our findings therefore revealed a previously unknown mechanism of UV-induced ocular inflammation related
to ROS and HMGB1 suggesting a new medical therapeutic target.
Cell Death and Disease (2015) 6, e1863; doi:10.1038/cddis.2015.199; published online 27 August 2015
High-mobility group box 1 (HMGB1) is a nuclear protein that
binds to DNA functioning as a DNA chaperone.1 Various
conditions such as acetylation, phosphorylation, or oxidation
cause posttranslational modification of HMGB1 while
influencing the location and action of HMGB1.2–5 Because
HMGB1 lacks a leader sequence, it can be transferred to the
extracellular space by a vesicular transport mechanism
known as the non-classical secretory pathway.6,7 HMGB1
can also be passively released after necrosis or late apoptosis
as a consequence of decreased plasma membrane
permeability.3,8,9 In the extracellular environment, HMGB1
interacts with various receptors including Toll-like receptor
(TLR)-2, -4, receptor for advanced glycation endproducts
(RAGEs), or CD24-Siglec-10 in order to deliver signals like an
alarmin.10,11 In addition, HMGB1 is reported to act as a late
mediator of endotoxemia and sepsis in animal models as well
as human patients through interactions with TLR4.12,13
The recruitment of inflammatory cells can be mediated
through interactions among HMGB1, RAGE, and CXCR4,14
wherein HMGB1 functions as a signaling molecule during cell
differentiation and migration in the extracellular space.15,16
Endogenous HMGB1 translocates from the nucleus to the
cytoplasm through a redox-dependent mechanism. In addi-
tion, cytoplasmic HMGB1 plays a role as a regulator between
macroautophagy and apoptosis.17 HMGB1 contains two
folded DNA-binding subunits known as A and B boxes along
with an acidic region. The HMGB1 A box has anti-
inflammatory effect whereas the B box has pro-inflammatory
effect by inducement in releasing various cytokines.
The purified recombinant A box functions as an antagonist
to B-box-induced cytokine production.18
HMGB1 is also reported to have an association with
numerous immune-mediated conditions, such as rheumatoid
arthritis, systemic lupus erythematosus (SLE), or inflamma-
tory myositis.19–21 Under such conditions, the expression of
HMGB1 increases in the blood, synovial tissue, skin lesions,
and especially in the cytoplasm as well as extracellular area of
patient specimens.19–21 Ultraviolet (UV) radiation triggers
cutaneous lupus erythematosus (CLE), and large amount of
extracellular HMGB1 was observed in skin lesions of lupus
erythematosus patients20 suggesting that UV radiation might
cause the translocation of HMGB1.
Conjunctiva surrounding an eye is also exposed to outer
environment like the skin does, and UV functions as its stimuli.
Increased UV radiation on ocular surface elevates the level of
oxidative stress causing induction of proteins, such as survivin
or p53, on ocular surface.22 Direct effects of both UV radiation
and UV-induced oxidative-free radicals can cause molecular
alterations in the p53, p63, and p73 genes, which, in turn, can
lead to alterations in cellular differentiation and cell cycle on
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conjunctiva.23–25 Alteration on ocular surface caused by UV
results chronic inflammation, which is the main pathogenesis
of pterygium.26,27 Indeed, high prevalence of pterygium was
noted in the equatorial zone of the tropics located within 30
degrees toward both North and South.28
On the basis of the previous findings regarding the
association between cytoplasmic and secreted HMGB1
protein and UV-related inflammatory diseases, we invested
the involvement of HMGB1 in chronic ocular surface inflam-
mation. In this study, we found that the level of HMGB1 and
reactive oxygen species (ROS) are increased in human
pterygial tissues. Moreover, we confirmed that UV exposure
and UV-induced oxidative stress could cause nucleo-
cytoplasmic translocation of HMGB1 followed by its extra-
cellular secretion using conjunctival epithelial cells. In amouse
model, HMGB1 played a critical role in chronic inflammatory
cell recruitment to the UV-irradiated area. Pretreatment of
HMGB1 neutralizing proteins or ROS scavengers could block
the chemotaxis of inflammatory cells suggesting that HMGB1
might be a possible therapeutic target for the treatment of UV-
induced pterygium formation.
Results
UV induces the nucleo-cytoplasmic translocation of
HMGB1 that results in secretion from conjunctival cells.
To observe whether UV-induced HMGB1 secretion is
associated with the inflammation that occurs during pter-
ygium development, we first observed whether UV radiation
could induce the nucleo-cytoplasmic translocation of HMGB1
in human conjunctival Chang cells. Chang conjunctival cells
were transiently transfected with an HMGB1-GFP plasmid
followed by irradiation with 20mJ/cm2 of UV, which induced
no significant necrotic cell death in conjunctival cells (data not
shown). However, we found translocation of HMGB1 to the
cytoplasm using confocal microscopy (Figure 1a). To observe
the endogenous HMGB1 movement, an immunofluorescence
assay was performed. As shown in Figure 1b, the transloca-
tion of endogenous HMGB1 was observed after UV treatment
by confocal microscopy and western blot analysis of the
cytosolic fraction of UV-treated Chang cells (Figure 1c). We
then examined if UV-induced secretion of HMGB1 to the
extracellular area had occurred. The results showed that the
level of HMGB1 in the culture supernatant of Chang cells was
significantly increased 8 h after the UV radiation (Figure 1d).
We assessed mRNA expression levels of cytokines in human
conjunctiva epithelial Chang cells in a time-dependent
manner. We found that MIP-1, IL-17, IL-8, and HMGB1 were
increased after the irradiation. At 7 h after exposure to UVB
light, the expression levels of MIP-1, IL-17, and IL-8 reached
maximum, while the HMGB1 levels were evaluated at 8 h
after UVB irradiation (Supplementary Figure S1).
UV-induced translocation of HMGB1 is inhibited by
antioxidants. UV induces ROS generation while activating
oxidative mechanisms.29,30 We therefore asked whether UV-
induced ROS generation occurred in Chang cells and if
treatment with antioxidants such as N-acetyl-L-cysteine
(NAC) and Mito-Tempo (Enzo Life Sciences, Farmingdale,
NY, USA) could reduce UV-induced ROS generation and
HMGB1 translocation. NAC is a precursor of glutathione that
acts as a scavenger for OH radicals, and Mito-Tempo (Enzo
Life Sciences) is a mitochondria-targeted antioxidant with
superoxide and alkyl radical scavenging properties. The
results presented that UV induced significant ROS formation,
which was reduced by NAC and Mito-Tempo (Enzo Life
Sciences) treatment (Figure 2a). The 8-OHdG level, one of
the markers of superoxide production, was significantly
increased in Chang cells after UV irradiation. NAC treatment
did significantly reduce the 8-OHdG level, but Mito-Tempo
(Enzo Life Sciences) treatment was slightly reduced
(P= 0.069; Figure 2b). Not surprisingly, we observed HMGB1
translocation in Chang cells inhibited by the antioxidants
(Figure 2c); oxidative potential is an important factor in
determining the location and function of HMGB1.5,31,32
sRAGE and HMGB1 A box protein inhibit UV-induced
leukocyte infiltration in mouse conjunctiva. We evaluated
the effect of UV on HMGB1-induced leukocyte infiltration in
BALB/c mice. The conjunctiva of mice were exposed to UV
(single dose of 100mJ/cm2) followed by the whole eye
removal 24 h after UV irradiation for immunohistochemical
analysis. UV radiation induced the infiltration of cells to the
mouse conjunctiva (Figure 3a), which predominantly were
composed with Gr-1+ or F4/80+ cells (Figure 3b). The
HMGB1 expression level was also elevated in conjunctival
epithelial cells (Figure 3c), and the HMGB1 protein was
translocated to the cytoplasm (Figure 3d), implying the
secretion of HMGB1. To verify whether UV-induced inflam-
mation was associated with HMGB1, we pretreated BALB/c
mice with sRAGE and HMGB1 A box proteins, which are a
well-known soluble decoy receptor of HMGB1 and an
inhibitory domain of HMGB1, respectively,18 followed by
irradiation with UV. Pretreatment with sRAGEs and the A box
of HMGB1 significantly reduced UV-induced cell infiltration
(Figure 3e). These results indicate that UV radiation after
conjunctival inflammation is highly associated with
HMGB1 secretion.
In vivo treatment of antioxidants reduces UV-induced
infiltration of inflammatory cells in mouse conjunctiva.
We investigated whether antioxidant treatment could inhibit
the infiltration of leukocytes in UV-treated mice. BALB/c mice
were treated with a single dose of 100mJ/cm2 UVB after
pretreatment with NAC (125mM, 2 h before UV) or Mito-
Tempo (Enzo Life Sciences, 135 μM, 24 h and 1 h before
UVB). At 24 h after UV radiation, whole eyes were enucleated
and observed for the infiltration of leukocytes by histological
analysis. NAC and Mito-Tempo (Enzo Life Sciences) pre-
treatment significantly reduced UV-induced infiltration of
leukocytes to the mouse conjunctiva (Figures 4a and b).
We conducted confocal microscopy in order to clearly confirm
that HMGB1 release in UV-induced inflammation can be
controlled with NAC and Mito-Tempo (Enzo Life Sciences).
We could find out clearer HMGB1 translocation after the UV
irradiation, and there was decrease in HMGB1 staining when
ROS quencher was pretreated (Figure 4c). These results
suggest that UV-induced ROS facilitates HMGB1 secretion,
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which is involved in the regulation of inflammatory responses
on the ocular surface.
Nucleo-cytoplasmic translocation of HMGB1 in human
pterygial tissue. A pterygium is a benign, invasive,
proliferative disease on conjunctiva, which is induced as
chronic inflammation26,27 resulting connective tissue remo-
deling. We first tested whether the pterygium conjunctival
tissue produced ROS because pterygium development is
correlated to the amount of exposure to the sunlight.28 ROS
was measured from the conjunctival tissues obtained
from two pterygium patients and their corresponding
superior bulbar conjunctival tissues as controls. Superior
bulbar conjunctival tissue is rarely exposed to UV ray since it
is usually covered with the eyelid. Pterygium conjunctival
tissues had high level of ROS expression compared to
the control conjunctiva (Figure 5a). Since the increase in
ROS causes oxidative stress followed by the translocation of
HMGB1,33 we investigated whether human conjunctival
tissues from pterygium exhibit cytoplasmic translocation of
HMGB1. Human conjunctival tissue was surgically obtained
from the pterygium and superior bulbar conjunctiva of five
patients followed by immunochemical stain for HMGB1.
Immunohistochemical staining and immunofluorescence
assays showed that conjunctival cells from pterygia had an
increased amount of cytoplasmic HMGB1 compared to the
control (Figure 5b). Notably, the western blot analysis showed
that the mean HMGB1 level in cytoplasmic fractions of
conjunctival tissues from the five patients was significantly
increased compared to that of control conjunctival tissues
Figure 1 UV-induced nucleo-cytoplasmic translocation of HMGB1 in human conjunctival epithelial Chang cells. (a) Chang cells were transiently transfected with an HMGB1-
GFP plasmid and then irradiated with 20 mJ/cm2 of UV followed by 8-h incubation. The number of cytoplasmic GFP-positive cells was counted among the 100 GFP-positive cells.
(b and c) An immunofluorescence assay was performed to observe the UV-induced translocation of endogenous HMGB1. Endogenous HMGB1 was immunostained using an
anti-HMGB1 antibody and a secondary anti-rabbit Alexa Fluor 594 antibody. Cytosolic proteins were fractionated from the lysates, and a western blot assay was performed.
(d) Chang cells were irradiated with 20 mJ/cm2 of UVand incubated for further 8 h. The HMGB1 level in the culture supernatant was then evaluated by western blot. Relative band
intensity was measured using the ImageJ program. Values shown are mean± S.E. *Po0.05 (n= 3)
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(Figure 5c). To measure the extracellular secretion of
HMGB1, we collected the media from cultured pterygium
and control tissues after 8 h of ELISA. HMGB1 levels in the
culture supernatant were increased in pterygium tissues
(Figure 5d). In addition, immunohistochemistry also showed
increased expression of CXCL12, one of the strong
chemotactic factors induced by HMGB114 in the pterygia
compared to normal conjunctiva (Supplementary Figure S2).
Taken together, these data present that ROS production
caused by UV induces chronic inflammation through HMGB1
translocation in the pterygial tissue and UV-induced ROS is
involved in the HMGB1-mediated pterygium formation.33,34
Discussion
In our study, we confirmed that HMGB1 was translocated in
the cytoplasm after UV treatment on ocular surface tissue.
Antioxidant treatment was found to reduce HMGB1 transloca-
tion while attenuating conjunctival inflammation by UV-
induced HMGB1 and decrease the infiltration of leukocytes
to the inflammatory site. Pretreatment with the HMGB1
inhibitors sRAGE and Box A of HMGB1 decreased UV-
induced leukocyte migration. There have been several studies
regarding HMGB1 stimulating the motility of various cell types
such as fibroblasts, dendritic cells, macrophages, smooth
muscle cells, and, most recently, neutrophils.35,36 As an
alarmin, treatment with a high concentration of recombinant
HMGB1 protein (5 μg/ml or 300 nM) was confirmed to attract
inflammatory cells through interactions with RAGE37 and
CXCR4.14 In chronic inflammatory disorders, such as rheu-
matoid arthritis, a high amount of HMGB1 was reported in the
target organ where it induced leukocyte recruitment, resulting
tissue damage.38
Figure 2 UV-induced ROS generation resulting in the translocation of HMGB1. (a) Chang cells were treated with 20 mJ/cm2 of UV with or without pretreatment with NAC and
Mito-Tempo (Enzo Life Sciences). Approximately, 5 µmol/l of DC-FDA was used to detect ROS generation. Mean fluorescence intensity was measured using FV1000 confocal
microscopy. *Po0.05 and **Po0.01 (n= 3). (b) Chang cells were treated with 20 mJ/cm2 of UV with or without pretreatment with NAC and Mito-Tempo (Enzo Life Sciences).
At 8 h after UV treatment, 8-OHdG levels were measured by ELISA. **Po0.01 (n= 3). (c) Chang cells were transfected with the HMGB1-GFP plasmid and incubated for 24 h.
UV treatment was performed with or without pretreatment with NAC (10 mM) and Mito-Tempo (Enzo Life Sciences, 50 nM) 1 h before UV radiation. After 8 h, the GFP-tagged
HMGB1 signal was visualized by confocal microscopy. The number of cytoplasmic HMGB1-GFP cells was then counted. Values shown are the mean± S.E. *Po0.05 (n= 3)
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We also demonstrated that UV-induced ROS generation
and oxidative stress caused HMGB1 extracellular secretion.
It was confirmed by pretreatment with an ROS quencher that
decreased UV-induced HMGB1 secretion. We hypothesize
that UVexposure induces the translocation of HMGB1 protein
to the extracellular environment where it recruits leukocytes to
the UV-exposed site causing ocular surface inflammation. We
could assume that the concentration of locally secreted
HMGB1 might be relatively high because small amounts of
HMGB1 protein did not attract neutrophils.37 Normal human
corneal cells express TLRs 1–10 while normal human uvea,
sclera, retina, and conjunctiva express mRNA associated with
TLR4 and its lipopolysaccharide receptor complex.39–41 In this
study, we could not specifically identify the receptors related to
the chemotactic effect of HMGB1. The exact receptors that
HMGB1 uses to induce its inflammatory effects therefore
require further evaluation. In addition, it would be worthwhile
to study the oxidative conditions of secreted HMGB1 SH
residues in pterygium samples because only the fully reduced
form of HMGB1, in which all three cysteines are in a thiol state,
can function as a chemoattractant.42
As a model disease, pterygium, the UV-induced chronic
ocular surface inflammation, we found increased HMGB1 and
ROScompared to the control samples. The oxidative condition
is one of the major factors affecting the localization and
function of HMGB1.5 The study demonstrated reduction in the
movement of HMGB1 caused by mitochondrial ROS inhibitor,
and it suggests possible interaction between HMGB1 and
Figure 3 UV-induced leukocyte infiltration was inhibited in mouse conjunctiva by HMGB1 A box and sRAGE treatments. (a and b) The conjunctiva of BALB/c mice were
exposed to UV (311 nm) at a single dose of 100 mJ/cm2 using a UV lamp 24 h after UV treatment. The whole eye was then enucleated for H&E staining, and the number of
infiltrated cells was counted. *Po0.05 (n= 10). (b) A representative conjunctival tissue was immunofluorescently stained against Gr-1 (green, upper) or F4/80 (green, lower) for
infiltrated leukocytes. DAPI was used to stain the nuclei. (c) Immunohistochemical staining of UV-exposed conjunctival tissue using an anti-HMGB1 antibody. (d) An
immunofluorescence assay was performed to observe UV-induced nucleo-cytoplasmic translocation of endogenous HMGB1. (e) BALB/c mice were pretreated with
sRAGEs (100 μg per mouse, 15 min before UV radiation) and HMGB1 A box protein (150 μg per injection, 1 h before and after UV radiation), and then treated with a single
dose of 100 mJ/cm2 UVB. At 24 h after UV treatment, the whole eyes were enucleated for H&E staining and the infiltrated leukocyte cells were counted. Values shown are the
mean±S.E. *Po0.05 (n= 10)
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mitochondrial system. HMGB1 is known to be located in the
mitochondria in HUVEC cells, and high-mobility group
A1 (HMGA1) protein, a nuclear transcription factor belonged
to the HMG family, was also found to be in the mitochondria in
several cell lines.43,44 Recently, there was a study confirming
that extracellular HMGB1 protein induces the phosphorylation
of RAGE, which then accumulates in mitochondria.45
We hypothesize that cytosolic HMGB1 might also be located
in mitochondria, and that mitochondrial electron transport
systems might influence the oxidative potential and location of
HMGB1. In addition, it is possible that HMGB1 secreted to the
extracellular environment might interact with various
receptors, promoting mitochondrial synthesis or mitochondrial
biogenetics.
UV irradiation can upregulate the expression of other
damage-associated molecular pattern (DAMP) molecules
such as heat shock proteins, and these molecules also depict
chemotactic effects.46–48 Moreover, other DAMP molecules
could be target molecules in UV-induced ocular surface
changes, including pterygium formation. We could confirm
the increase in IL-8 in our Chang cell study. It is already proven
that IL-8 is an UV-mediated cytokine in the pterygium and
human pterygium epithelial cell through the previous study.23
It is possible that HMGB1 might induce the secretion of these
Figure 4 Antioxidant treatment reduced UV-induced infiltration of inflammatory cells to the conjunctiva. BALB/c mice were intraperitoneally treated with NAC (125 mM, n= 5) and
Mito-Tempo ( Enzo Life Sciences, 135 μM, n= 5) and then exposed to 10 mJ/cm2 of UVB. The eyes were enucleated on 24 h after UV treatment. (a) Histologic analysis was performed
with H&E staining. The number of leukocyte cells was counted and the mean±S.E. was obtained. *Po0.05. (b) Immunohistochemical staining of the eye tissue using an anti-HMGB1
antibody. (c) Immunofluorescence confocal microscopy was performed with monoclonal antibody of HMGB1 (red) and DAPI (blue). Surface of the cornea epithelium (dotted line)
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cytokines through interactions with other membranous
receptors. This study proved a profound role of HMGB1 for
UV-induced inflammation in conjunctive. However, lack
of detailed experiments regarding mechanisms or pathways
of HMGB1 release still remains as a limitation of the study.
In conclusion, we report that ocular surface inflammation
caused by UVexposure results HMGB1 translocation, and it is
originated fromROS generation. Our findings were identical to
the previously unknown mechanism of ocular surface inflam-
mation, suggesting a new medical therapeutic target for
UV-induced changes regulating its development.
Materials and Methods
Mice conjunctival UV exposure model. Six- to eight-week-old female
BALB/c mice were purchased from Charles River Laboratories (Orient Bio Inc.,
Sungnam, Korea). The conjunctivas of BALB/c mice were exposed to UV radiation
(311 nm wavelength) at a single dose of 100 mJ/cm2 using a UV lamp
(Philips, Eindhoven, Holland). To block the effect of HMGB1, mice were injected
intraperitoneally with 100 μg of sRAGE 15 min before UV radiation or with 150 μg of
HMGB1 A box 1 h before and after UV radiation. For inhibition of ROS production,
mice were intraperitoneally injected with an ROS scavenger consisting of 125 mM
NAC (Sigma-Aldrich, St. Louis, MO, USA) 2 h before UV radiation or with 135 μM
Mito-Tempo (Enzo Life Sciences) 24 h and 1 h before UV radiation, respectively, and
were then killed 24 h after UV radiation.
Cell culture and DNA transfection. Human conjunctival epithelial Chang
cells were purchased from the Korean Cell Line Bank (KCLB, Seoul, South Korea)
and cultured at 37 °C under 5% CO2 in RPMI 1640 medium containing 2 mM
L-glutamine, 25 mM HEPES, 25 mM NaHCO3, 10% FBS, 100 U/ml penicillin, and
100 μg/ml streptomycin (Gibco, Invitrogen, Carlsbad, CA, USA). Transient
transfection of the HMGB1-GFP plasmid was performed using FuGENE HD
(Promega, Mannheim, Germany).49
Figure 5 ROS production and cytoplasmic HMGB1 increased in conjunctival tissue from pterygium patients. (a) Two pterygium conjunctival tissues were excised and
incubated with 5 μM of DC-FDA in culture medium. ROS levels were measured by FV1000 confocal microscopy. ROS levels were elevated in the two pterygium conjunctival
tissues compared to the superior bulbar conjunctival tissues from the same two patients. (b) Human pterygial tissues were surgically resected from five patients, and
immunohistochemical (left) and immunofluorescence (right) assays were performed for detecting HMGB1. Control conjunctival tissues were obtained from the superior bulbar
conjunctiva of the same patients. (c) Cytosolic proteins were fractionated from the pterygium (P) and control (C) conjunctiva lysates followed by a western blot assay. (d) Secretory
HMGB1 levels in the culture supernatant were determined by ELISA and means± S.E. are shown. *Po0.05 (n= 5)
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Protein preparation. Recombinant wild-type HMGB1 and mouse sRAGE-Fc
protein were produced in CHO cells (A&R Therapeutics, Daejeon, Republic of
Korea) and HMGB1 box A (aa 1–79) was produced in E. coli BL21 (DE3) pLysE
followed by purification using the Ni2+-NTA system, Sephadex G75 medium,
and ion-exchange column.50 Endotoxin was removed using Triton
X-114 (Calbiochem, La Jolla, CA, USA).51
UV radiation. Chang cells were cultured in a 100-mm culture dish and grown
until they reached semi-confluence. The medium was aspirated and the cells were
washed three times with cold PBS prior to UV irradiation. UV intensity was
monitored and calibrated before each experiment with the aid of a model-500-C
radiometer (National Biological Corporation, Twinsborg, OH, USA). After UV
exposure, cells were re-washed three times with cold PBS and incubated for further
8 h in culture medium.
Treatment of ROS scavengers and detection of ROS. To detect the
ROS generated by UV radiation, Chang cells were irradiated with UV, and 5 μM of
dichlorodihydrofluorescein diacetate (DC-FDA; Molecular Probes Inc., Eugene, OR, USA)
was added to the culture medium and incubated for 30 min. The UV-generated ROS level
was observed by FV1000 confocal microscopy (Olympus, Tokyo, Japan). To observe UV-
induced cytoplasmic HMGB1 translocation, Chang cells were transiently transfected with
an HMGB1-GFP plasmid and treated with 10 mM NAC or 50 nM Mito-Tempo (Enzo Life
Sciences) for 1 h followed by UV radiation. Cells were cultured for further 8 h after UV
radiation after which GFP-tagged HMGB1 protein or endogenous HMGB1 were
immunostained using an anti-HMGB1 antibody (Ab) and observed by confocal
microscopy. We counted 100 GFP-positive cells in multiple random visual fields in each
condition and compared the results to the number of cytoplasmic HMGB1-containing
cells for nucleo-cytoplasmic translocation.
Nuclear and cytoplasmic extraction. The extraction of nuclear and
cytoplasmic fractions was performed using a nuclear/cytosol fractionation kit
(BioVision, Mountain View, CA, USA) following the manufacturer’s protocol. Briefly,
cells were harvested and cytoplasmic extraction buffer A mix (containing DTT and
protease inhibitors) and CEB-B were added consecutively to extract the cytoplasmic
proteins. After separating the cytoplasmic extract, a nuclear extraction buffer (NEB)
mix (containing DTTand protease inhibitors) was added and the nuclear extract was
separated by centrifugation.
Western blot analysis. Chang cells were lysed using Pro-Prep protein extraction
solution (Intron, Seongnam, Korea) that included a mixture of protease inhibitors (Sigma-
Aldrich). The protein concentration was determined by using the bicinchoninic acid (BCA)
assay (Pierce Thermo Scientific, Rockford, IL, USA). Protein samples were loaded on a
12% SDS-PAGE gel and transferred to nitrocellulose membranes. Western blot analysis
was performed using primary Abs against HMGB1 (Abcam, Cambridge, UK), β-actin
(Santa Cruz Biotechnology Inc, Santa Cruz, CA, USA), LDH (Santa Cruz Biotechnology
Inc), and α-tubulin (Santa Cruz Biotechnology Inc), and HRP-labeled goat anti-rabbit or
goat anti-mouse secondary Abs (Jackson Immuno Research Labs Inc, West Grove, PA,
USA). ECL was used to reveal the signals (Thermo Scientific, Rockford, IL, USA), and
band intensities were measured using the ImageJ program (NIH, Bethesda, MD, USA).
To compare the HMGB1 secretion levels, cells were seeded into 60-mm plates and
maintained in OPTI-MEM (Gibco, Invitrogen). UV was irradiated when the cells were
semi-confluent, after which they were incubated for further 8 h. Cell culture supernatants
were then collected and concentrated using a centrifugal filter unit (Millipore, Billerica, MA,
USA) followed by western blot analysis using an anti-HMGB1 Ab.
ELISA to detect secretory HMGB1 levels. Secretory HMGB1 levels in
the culture supernatant of pterygium and control tissues were determined by ELISA
with reference to the standard curve for purified HMGB1 (Shino-Test, Tokyo, Japan),
obtained with serial dilutions. The concentrations of the purified HMGB1 standard
ranged from 0 to 160 ng/ml.
cDNA synthesis and real-time quantitative PCR. The human
conjunctiva epithelial Chang cells at different time points following UVB irradiation
were collected. Total RNA was extracted with TRIzol reagent (Invitrogen, Carlsbad,
CA, USA), and 5 μg of RNA was converted into cDNA using Superscript II reverse
transcriptase with oligo (dT) primer (Thermo Scientific). The products were used as
a template for each chemokine-specific real-time PCR set for the amplification of
MIP-1, MCP-1, IL-17, IL-8, and HMGB1. Quantitative PCR amplifications were
performed using SYBR Green (Thermo Scientific) in a Chromo4 real-time
thermocycler (Bio-Rad, Hercules, CA, USA).
Detection of 8-hydroxy-2-deoxy guanosine concentration. Chang
cells were harvested and DNA was isolated using a genomic DNA extraction kit
(Qiagen, Valencia, CA, USA). The amount of 8-hydroxy-2-deoxy guanosine was
determined using an OxiSelect oxidative DNA damage ELISA kit (Cell Biolabs, San
Diego, CA, USA) according to the manufacturer's instructions.
Histological analysis. The conjunctivas of BALB/c mice were exposed to UV
(311 nm wavelength) at a single dose of 100 mJ/cm2 using a UV lamp (Philips).
For histological analysis, 24 h after UV treatment, whole eyes were enucleated and
were fixed in 1% paraformaldehyde followed by routine paraffin embedding.
Sections were stained with H&E, and the number of infiltrated leukocytes was
counted by light microscopy at the bulbar and fornical regions of the conjunctiva
field using a magnification of × 200 for each H&E-stained slide.
Frozen sections were also prepared for additional mouse experiments as well as
with human pterygium tissues. Whole eyes were enucleated from mice 24 h after the
conjunctiva were exposed to UV (single dose of 100 mJ/cm2) and were frozen after
embedding in OCT solution. Frozen 6-μm-thick sections were blocked with 2% BSA in
PBS for 45 min and incubated overnight at 4 °C with the following primary Abs: rabbit
anti-HMGB1 (Abcam), rabbit anti-mouse F4/80 (eBioscience, San Diego, CA,USA),
and rat anti-mouse Gr-1 (BD Pharmingen, eBioscience); an isotype-matched Ab was
used as a control. The following day, the sections were incubated with Alexa Fluor
488- or Alexa Fluor 594-conjugated secondary Ab at room temperature for 1 h.
Sections were mounted with DAPI-containing mounting medium, and were examined
under a confocal microscope.
For immunohistochemical staining, the 4-μm paraffin tissue sections were de-
paraffinized, rehydrated, and treated with an antigen retrieval solution (10 mM sodium
citrate buffer, pH 6.0). The sections were incubated with a dilution of 1 : 1000 rabbit anti-
human HMGB1 Ab (Abcam) and mouse monoclonal anti-human CXCL12 (R&D Systems,
Minneapolis, MN, USA) overnight at 4 °C, and then incubated with polymer-HRP Ab
(DAKO, Glostrup, Denmark) for 20 min at room temperature according to manufacturer's
instructions. Finally, tissue sections were incubated with DAB (Sigma-Aldrich) until a brown
color developed, before the sections were counterstained with hematoxylin.
Immunofluorescence and confocal imaging. Cells were cultured in a
four-chamber slide (Nunc, Naperville, IL, USA) and fixed with 4% paraformaldehyde
for 20 min at RT. After fixation, cells were washed three times with cold PBS and
permeabilized with 0.2% Triton X-100 for 10 min, and then blocked with 1% BSA-
PBS for 1 h at RT. Cells were then incubated overnight at 4 °C with primary Abs that
had been diluted in 1% BSA-PBS. The cells were washed three times with cold
PBS, and Alexa Fluor 488- or Alexa Fluor 594-conjugated secondary Abs
(Invitrogen) were added for 1 h. The cells were washed three times with cold PBS
and mounted with Vectashield mounting solution (Vector Laboratories, Burlingame,
CA, USA) and observed under a confocal microscope.
Statistical analysis. The statistical analysis was performed by using the
Student’s t-test. All data are presented as mean± S.E.
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